Marinomed Biotech AG | WebDisclosure

Basculer en Français

8300	Companies
115014	Keywords
55394	Articles
62493	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 03/01/2024 at 07:50, 8 months 20 days ago

Marinomed Biotech AG annonce la nomination d'un nouveau responsable des relations avec les investisseurs et le public

Marinomed Biotech Relations Avec Les Investisseurs Relations Publiques Lucie Ziegler Annonce D'entreprise
BRIEF

published on 03/01/2024 at 07:50, 8 months 20 days ago

Marinomed Biotech AG Announces New Head of Investor & Public Relations

Investor Relations Corporate Announcement Marinomed Biotech Public Relations Lucia Ziegler
PRESS RELEASE

published on 03/01/2024 at 07:45, 8 months 20 days ago

Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
Marinomed Biotech AG appoints Lucia Ziegler as new Head of Investor & Public Relations, integrating IR activities with PR for better stakeholder communication

Investor Relations Marinomed Biotech AG Public Relations Lucia Ziegler Stakeholder Communication
PRESS RELEASE

published on 02/14/2024 at 07:45, 9 months 7 days ago

Marinomed Biotech AG announces preliminary revenue for 2023
Marinomed Biotech AG announces preliminary revenue for 2023, with cash stability through cost management and funding program. Outlook includes new product launches and market expansions

Marinomed Biotech AG Preliminary Revenue Cash Management Product Launches Market Expansion
PRESS RELEASE

published on 02/07/2024 at 07:45, 9 months 14 days ago

Marinomed Biotech AG with important progress for Carragelose in 2024
Marinomed Biotech AG enrolls first patient in clinical study for Carragelose eye drops and receives patents in Singapore, South Korea, and Brazil, strengthening its IP portfolio. The company plans to launch Carragelose eye drops and nasal spray in 2024, targeting allergy and eye care markets

Clinical Study Marinomed Biotech AG Carragelose Patents Allergy And Eye Care Markets
PRESS RELEASE

published on 10/17/2023 at 07:45, 1 year 1 month ago

Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume
PRESS RELEASE

published on 08/17/2023 at 07:45, 1 year 3 months ago

Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities
PRESS RELEASE

published on 08/09/2023 at 07:45, 1 year 3 months ago

Marinomed enters first long-term Solv4U partnership with Shanghaibased SPH Sine Pharmaceutical Laboratories Co. Ltd.
PRESS RELEASE

published on 07/27/2023 at 07:45, 1 year 3 months ago

Marinomed Biotech AG: M8 Pharmaceuticals obtains market authorization for Carragelose nasal spray in Mexico
PRESS RELEASE

published on 07/13/2023 at 07:45, 1 year 4 months ago

Peer-reviewed publication by Marinomed Biotech AG and Friedrich-Alexander-University Erlangen-Nürnberg reconfirms broad virus-blocking effectiveness of iota-carrageenan

Accesswire

Published on 11/21/2024 at 15:30, 29 minutes ago

CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
Published on 11/21/2024 at 15:05, 54 minutes ago

"The Not-So-Secret Lives of REAL 'Mormon' Wives" - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/21/2024 at 15:00, 59 minutes ago

2-10 Home Buyers Warranty Makes Triumphant Entry Into Oklahoma Market
Published on 11/21/2024 at 15:00, 59 minutes ago

Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program
Published on 11/21/2024 at 15:00, 59 minutes ago

BlackBerry AtHoc "In Process" Finalization for FedRAMP High Authorization

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 15:41, 17 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 37 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 15:20, 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc

Les Echos

Published on 11/21/2024 at 06:58, 9 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 1 minute ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 9 hours 1 minute ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 19 hours 52 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 20 hours 39 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE